TABLE 1.
Total | Non‐anastomotic | Anastomotic | p‐value | |
---|---|---|---|---|
N = 42 | N = 15 | N = 27 | ||
Gender | 0.43 | |||
Female | 31 (74%) | 10 (67%) | 21 (78%) | |
Male | 11 (26%) | 5 (33%) | 6 (22%) | |
Age | 54.2 (11.7) | 60.1 (11.1) | 50.9 (10.8) | 0.012 |
Age category | 0.14 | |||
18–45 | 10 (24%) | 1 (7%) | 9 (33%) | |
45–54 | 13 (31%) | 4 (27%) | 9 (33%) | |
55–64 | 14 (33%) | 7 (47%) | 7 (26%) | |
>65 | 5 (12%) | 3 (20%) | 2 (7%) | |
Anatomic region | <0.001 | |||
GJA and EJA | 22 (52%) | 0 (0%) | 22 (81%) | |
Esophagus | 3 (7%) | 2 (13%) | 1 (4%) | |
Gastric and duodenal | 14 (33%) | 13 (87%) | 1 (4%) | |
Colorectal | 3 (7%) | 0 (0%) | 3 (11%) | |
Specific location | <0.001 | |||
GJA | 19 (45%) | 0 (0%) | 19 (70%) | |
Colorectal | 3 (7%) | 0 (0%) | 3 (11%) | |
duodenal bulb | 4 (10%) | 3 (20%) | 1 (4%) | |
Jejunal | 2 (5%) | 2 (13%) | 0 (0%) | |
Pyloric | 8 (19%) | 8 (53%) | 0 (0%) | |
gastroesophageal junction | 1 (2%) | 0 (0%) | 1 (4%) | |
Esophageal | 3 (7%) | 2 (13%) | 1 (4%) | |
EJA | 2 (5%) | 0 (0%) | 2 (7%) | |
Stenosis diameter (mm) | 3.0 (3.0‐5.0) | 3.0 (3.0‐4.0) | 4.0 (3.0‐6.0) | 0.096 |
<5 mm | 30 (71%) | 14 (93%) | 16 (59%) | 0.019 |
≥5 mm | 12 (29%) | 1 (7%) | 11 (41%) | |
Stenosis length (mm) | 5.0 (3.0‐8.0) | 5.0 (3.0‐5.0) | 5.0 (5.0‐10.0) | 0.07 |
>5 mm | 14 (33%) | 3 (20%) | 11 (41%) | 0.17 |
≤5 mm | 28 (67%) | 12 (80%) | 16 (59%) | |
Pre‐LAMS symptoms | ||||
Dysphagia | 24 (71%) | 8 (62%) | 16 (76%) | |
Semi‐solids | 7 (32%) | 2 (29%) | 5 (33%) | |
Liquids | 7 (32%) | 2 (29%) | 5 (33%) | |
Total dysphagia | 8 (36%) | 3 (43%) | 5 (33%) | |
Vomiting | 28 (82%) | 11 (85%) | 17 (81%) | |
abdominal pain | 23 (68%) | 7 (54%) | 16 (76%) | |
abdominal distension | 14 (41%) | 6 (46%) | 8 (38%) | |
Constipation | 21 (62%) | 7 (54%) | 14 (67%) | |
Thin stool caliber | 14 (41%) | 6 (46%) | 8 (38%) |